<?xml version="1.0" encoding="UTF-8"?>
<p>The genetic material of BatIVs is similar to classic flu viruses, but their surface glycoproteins haemagglutinin (HA) and neuraminidase (NA) are evolutionarily and functionally diverged (Li et al., 
 <xref rid="B25" ref-type="bibr">2012</xref>; Zhu et al., 
 <xref rid="B47" ref-type="bibr">2012</xref>; Sun et al., 
 <xref rid="B38" ref-type="bibr">2013</xref>; Tong et al., 
 <xref rid="B41" ref-type="bibr">2013</xref>). BatIVs cannot be cultured in embryonated chicken eggs and do not agglutinate red blood cells (Tong et al., 
 <xref rid="B40" ref-type="bibr">2012</xref>, 
 <xref rid="B41" ref-type="bibr">2013</xref>). Initial efforts by researchers to isolate live infectious BatIVs directly from bats failed, due to unavailability of permissive cell lines (Ciminski et al., 
 <xref rid="B10" ref-type="bibr">2017</xref>). In addition, research on these viruses was further complicated by the dearth of bat cell lines and the limited bat genomic data. Attempts to circumvent these limitations have included: (i) using HA-17 or HA-18 pseudotyped vesicular stomatitis virus (VSV) and HIV-1 based lentiviruses (Hoffmann et al., 
 <xref rid="B18" ref-type="bibr">2016</xref>; Maruyama et al., 
 <xref rid="B27" ref-type="bibr">2016</xref>; Carnell et al., 
 <xref rid="B6" ref-type="bibr">2018</xref>; Giotis et al., 
 <xref rid="B16" ref-type="bibr">2019</xref>), (ii) engineering BatIV/IAV chimaeric viruses (Juozapaitis et al., 
 <xref rid="B22" ref-type="bibr">2014</xref>; Zhou et al., 
 <xref rid="B46" ref-type="bibr">2014</xref>), and (iii) reconstructing authentic BatIVs using reverse genetics (Moreira et al., 
 <xref rid="B30" ref-type="bibr">2016</xref>; Sato et al., 
 <xref rid="B36" ref-type="bibr">2019</xref>; Zhong et al., 
 <xref rid="B45" ref-type="bibr">2019</xref>). HA17-VSV was able to infect bat cell lines (EidNi, HypNi, and EpoNi) but only a few of the common Fl
 <sup>âˆ’</sup>M cell lines, including human U-87 MG glioblastoma and SK-Mel-28 melanoma cells, canine RIE 1495 and MDCK II kidney cells (Hoffmann et al., 
 <xref rid="B18" ref-type="bibr">2016</xref>; Maruyama et al., 
 <xref rid="B27" ref-type="bibr">2016</xref>; Moreira et al., 
 <xref rid="B30" ref-type="bibr">2016</xref>). The identification of MDCK II, in particular, as susceptible cell lines to BatIVs opened the way for a more comprehensive characterization of these strains (Moreira et al., 
 <xref rid="B30" ref-type="bibr">2016</xref>; Giotis et al., 
 <xref rid="B16" ref-type="bibr">2019</xref>; Karakus et al., 
 <xref rid="B23" ref-type="bibr">2019</xref>).
</p>
